Expression of Id-1 and VEGF in non-small cell lung cancer

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 10, 2013, Pages 2102-2111

  Kim, Mee Seon ^a   Park, Tae In ^a   Lee, Yu Mi ^a   Jo, Young Min ^a   Kim, Sunzoo ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Id proteins; Metastasis; Non Small Cell Lung Cancer; Prognosis; Vascular endothelial growth factor (VEGF)

Indexed keywords

ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; VASCULOTROPIN A;

AGED; ARTICLE; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; ID PROTEINS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); NON-SMALL CELL LUNG CANCER; PATHOLOGY; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

ID PROTEINS; METASTASIS; NON-SMALL CELL LUNG CANCER; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF);

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885346383     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lammli J, Fan M, Rosenthal HG, Patni M, Rinehart E, Vergara G, Ablah E, Wooley PH, Lucas G and Yang SY. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma. Int Orthop 2012; 36: 2307-2313.
2. Yu L, Deng L, Li J, Zhang Y and Hu L. The prognostic value of vascular endothelial growth factor in ovarian cancer: a systematic review and meta-analysis. Gynecol Oncol 2013; 128: 391-396.
3. Koo PJ, Morgensztern D, Boyer JL and Herbst RS. Targeting vascular endothelial growth fac tor in patients with squamous cell lung cancer. J Clin Oncol 2012; 30: 1137-1139.
4. Das M and Wakelee H. Targeting VEGF in lung cancer. Expert Opin Ther Targets 2012; 16: 395-406.
5. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci 2000; 113: 3897-3905.
6. Yokota Y. Id and development. Oncogene 2001; 20: 8290-8298.
7. Jen Y, Manova K and Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev Dyn 1996; 207: 235-252.
8. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra R. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401: 670-677.
9. Song X, Liu S, Qu X, Hu Y, Zhang X, Wang T and Wei F. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1. Acta Biochim Biophys Sin (Shanghai) 2011; 43: 796-804.
10. Kim HJ, Chung H, Yoo YG, Kim H, Lee JY, Lee MO and Kong G. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha. Mol Cancer Res 2007; 5: 321-329.
11. Maw MK, Fujimoto J and Tamaya T. Overexpression of inhibitor of DNA-binding (ID)-1 protein related to angiogenesis in tumor advancement of ovarian cancers. BMC Cancer 2009; 9: 430.
12. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang Q, Wang X and Wong YC. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 2005; 26: 1668-1676.
13. Ling MT, Wang X, Zhang X and Wong YC. The multiple roles of Id-1 in cancer progression. Differentiation 2006; 74: 481-487.
14. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist 2000; 5 Suppl 1: 3-10.
15. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L and Alitalo K. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998; 95: 14389-14394.
16. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM and Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-1478.
17. Ferrara N and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
18. Hasan J, Byers R and Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002; 86: 1566-1577.
19. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 1993; 362: 841-844.
20. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M and Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 1997; 57: 4593-4599.
21. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R and Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-1201.
22. Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin ZX, Liu J and Huang L. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2012; 363: 135-145.
23. Wang H, Yu Y, Guo RW, Shi YK, Song MB, Chen JF, Yu SY, Yin YG, Gao P and Huang L. Inhibitor of DNA binding-1 promotes the migration and proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem 2010; 335: 19-27.